RELATED STUDY
Treatment of a hyperkinetic movement disorder during pregnancy with dronabinol.
Key Findings: Reduction of hyperkinetic movement disorder.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): United States
Year of Pub: 2009
Cannabinoids Studied: Tetrahydrocannabinol (THC), Pharma THC
Phytocannabinoid Source: Not Applicable
Chemotype: Chemotype I
Sub-Ratio: 1:0 (THC:CBD)
Route of Administration: Oral (Ingestion)
Citation: Farooq MU, et al. Treatment of a hyperkinetic movement disorder during pregnancy with dronabinol. Parkinsonism Relat Disord. 2009; 15:249-51. doi: 10.1016/j.parkreldis.2008.04.039
Authors: Farooq MU, Ducommun E, Goudreau J
